Archford Capital Strategies’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $65.5K | Sell |
|
|||||
|
2025
Q2 | $65.3K | Hold |
|
|||||
|
2025
Q1 | $62.2K | Hold |
|
|||||
|
2024
Q4 | $96.4K | Sell |
|
|||||
|
2024
Q3 | $108K | Hold |
|
|||||
|
2024
Q2 | $72.2K | Sell |
|
|||||
|
2024
Q1 | $265K | Buy |
|
|||||
|
2023
Q4 | $196K | Sell |
|
|||||
|
2023
Q3 | $615K | Sell |
|
|||||
|
2023
Q2 | $952K | Sell |
|
|||||
|
2023
Q1 | $814K | Buy |
|
|||||
|
2022
Q4 | $601K | Sell |
|
|||||
|
2022
Q3 | $480K | Buy |
|
|||||
|
2022
Q2 | $330K | Buy |
|
|||||
|
2022
Q1 | $693K | Buy |
|
|||||
|
2021
Q4 | $1.47M | Sell |
|
|||||
|
2021
Q3 | $1.87M | Buy |
|
|||||
|
2021
Q2 | $2.54M | Buy |
|
|||||
|
2021
Q1 | $2.3M | Buy |
|
|||||
|
2020
Q4 | $2.35M | Buy |
|
|||||
|
2020
Q3 | $564K | Buy |
|